Monopar Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Monopar Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Wilmette
- Headquarters state / province
- Illinois
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MNPR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001645469
- EIN
- 32-0463781
Board of directors
-
Arthur J. Klausner · DirectorSince 2023
-
Chandler Robinson · Director · Chief Executive OfficerSince 2023
-
Christopher M. Starr · DirectorSince 2023
-
Kim R. Tsuchimoto · Director · Chief Financial OfficerSince 2023
-
Lavina Talukdar · DirectorSince 2025
-
Michael J. Brown · DirectorSince 2023
-
Nicole Sweeny · DirectorSince 2026
-
Raymond Anderson · DirectorSince 2023
Chief executives
Chandler Robinson
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 22, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
84.7%
-
87.2%
-
94.2%
-
98.7%
-
99.0%
Board connections
1 of this board's directors also sit on 1 other board.
- via Michael J. Brown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $104,925
- 1 purchase by 1 insider
- Sold, last 12 months
- $3,707,607
- 16 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Chandler Robinson Director, Officer (Chief Executive Officer) | Option exercise | +14,056 | $30.00 | $421,680 |
| Sep 24, 2026 | Chandler Robinson Director, Officer (Chief Executive Officer) | Option exercise | +15,000 | $14.00 | $210,000 |
| Sep 24, 2026 | Chandler Robinson Director, Officer (Chief Executive Officer) | Open-market sale | −10,450 | $87.15 | $910,718 |
| Sep 24, 2026 | Chandler Robinson Director, Officer (Chief Executive Officer) | Open-market sale | −9,638 | $87.96 | $847,758 |
| Sep 24, 2026 | Chandler Robinson Director, Officer (Chief Executive Officer) | Open-market sale | −8,368 | $88.97 | $744,501 |
| Sep 24, 2026 | Chandler Robinson Director, Officer (Chief Executive Officer) | Open-market sale | −600 | $89.79 | $53,874 |
| Aug 26, 2026 | Kim R. Tsuchimoto Director | Open-market sale | −485 | $108.83 | $52,783 |
| Aug 26, 2026 | RIOUX PATRICE Acting Chief Medical Officer | Option exercise | +1,380 | $0.01 | $7 |
| Aug 26, 2026 | Kim R. Tsuchimoto Director | Open-market sale | −615 | $109.56 | $67,379 |
| Aug 26, 2026 | RIOUX PATRICE Acting Chief Medical Officer | Open-market sale | −1 | $111.26 | $111 |
| Aug 26, 2026 | Kim R. Tsuchimoto Director | Open-market sale | −700 | $110.65 | $77,455 |
| Aug 26, 2026 | Kim R. Tsuchimoto Director | Open-market sale | −1,098 | $111.84 | $122,800 |
| Aug 26, 2026 | Kim R. Tsuchimoto Director | Open-market sale | −602 | $112.93 | $67,984 |
| Aug 26, 2026 | Kim R. Tsuchimoto Director | Open-market sale | −590 | $113.84 | $67,166 |
| Aug 25, 2026 | Raymond Anderson Director | Open-market sale | −694 | $110.04 | $76,368 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.